HF 1516 (see companion bill SF 990) – MinnesotaStatus: Inactive / Dead
Year Introduced: 2021
Pharmacy and provider choice allowed relating to biological product prescription and dispensation, and report required.
(a) A pharmacy benefit manager or health carrier must not require or demonstrate a preference for a pharmacy or health care provider to prescribe or dispense any of the following: (1) a reference biological product; (2) any product that is biosimilar to the reference biological product; or (3) any product that is an interchangeable biological product, relative to the reference
biological product. (b) If a pharmacy benefit manager or health carrier elects coverage of a product listed in paragraph (a), clauses (1) to (3), it must also elect equivalent coverage for all of the products listed in paragraph (a), clauses (1) to (3). (c) Nothing in this section must require switching from a prescribed product listed in paragraph (a), clauses (1) to (3), to another product listed in paragraph (a), clauses (1) to(3), that has a higher retail price.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.